[{"NetIncomeLoss_1_Q2_USD":-19421000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":105331000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":105331000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":37559000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":14700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":32800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-208000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1141600.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.04,"AccruedLiabilitiesCurrent_0_Q2_USD":12917000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermDebt_2_Q2_USD":10524000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":2997000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":32799691.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":30251805.0,"RestrictedCashCurrent_0_Q2_USD":10000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4177000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":14000.0,"AssetsCurrent_0_Q2_USD":217466000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q2_USD":12917000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.88,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5511000.0,"ShareBasedCompensation_2_Q2_USD":4044000.0,"Assets_0_Q2_USD":224980000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":-3758000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-324000.0,"CommonStockSharesIssued_0_Q2_shares":36802139.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":585000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":991000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":1003000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7588812.0,"IncomeTaxCreditsAndAdjustments_2_Q2_USD":1412000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":66753000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":104583000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8753000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":12.02,"MarketableSecuritiesCurrent_0_Q2_USD":62423000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2_Q2_USD":8.97,"CommonStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":9.24,"IncomeTaxExpenseBenefit_1_Q2_USD":1129000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1305000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":512000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q2_pure":0.0785,"OtherNonoperatingIncomeExpense_2_Q2_USD":22000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-585000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":142000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":31000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.04,"ResearchAndDevelopmentExpense_1_Q2_USD":20257000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":39025000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-585000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":419000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.034,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.062,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":7.8,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":9000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":9.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":262608.0,"Liabilities_0_Q2_USD":57495000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":424855000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5259000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":146242000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2808000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-19736000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-39488000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":991000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":112976000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":105689000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.46,"AccountsPayableCurrent_0_Q2_USD":2855000.0,"LiabilitiesCurrent_0_Q2_USD":35360000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-37330000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_2_Q2_USD":-259000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1996000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":4044000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":14000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-18292000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":13000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-315000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":4537986.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":2100000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":3300000.0,"RestrictedCashNoncurrent_0_Q2_USD":450000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-38196000.0,"InterestExpense_2_Q2_USD":452000.0,"InterestExpense_1_Q2_USD":209000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":146702000.0,"NetIncomeLoss_2_Q2_USD":-39501000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1553000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":16000000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":21000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":113808.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_Q2_shares":131147.0,"ProceedsFromDebtNetOfIssuanceCosts_2_Q2_USD":16834000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":141027000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":32800000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":36000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5518000.0,"CommonStockSharesOutstanding_0_Q2_shares":36802139.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7517000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":113236000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2383602.0,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":8.51,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":17230000.0,"InvestmentIncomeInterest_1_Q2_USD":207000.0,"InvestmentIncomeInterest_2_Q2_USD":733000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":278000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.52,"IncomeTaxesReceivable_0_Q2_USD":276000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":382000.0,"OperatingIncomeLoss_1_Q2_USD":-18217000.0,"OperatingIncomeLoss_2_Q2_USD":-37914000.0,"CommonStockSharesAuthorized_0_Q2_shares":90000000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":73000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":248000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_2_Q2_shares":171327.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":224980000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4044000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4537986.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":92000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":243000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":271000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":16784000.0,"StockholdersEquity_0_Q2_USD":167485000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":92000.0,"ProfitLoss_2_Q2_USD":-39501000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.31,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.59,"OperatingExpenses_1_Q2_USD":24434000.0,"OperatingExpenses_2_Q2_USD":47778000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1355000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_Q2_shares":26727.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1996000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-257162000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":649000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]